Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review



Aeglea BioTherapeutics Inc (Aeglea), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes human enzymes for the treatment of cancer and rare genetic diseases. The company’s lead product candidate pegzilarginase (AEB1102), is used for the treatment of arginase deficiency. It also develops ACN00177, for treating classical homocystinuria, a rare disease cause due to hereditary genetic deficiency. Aeglea also provides enzyme solutions to treat diseases with unmet medical needs. The company works in partnership with research institutions, healthcare providers and pharmaceutical companies to advance its pipeline products. Aeglea is headquartered in Austin, Texas, the US.

Aeglea BioTherapeutics Inc Key Recent Developments

May 07,2020: Aeglea BioTherapeutics reports first quarter 2020 financial results and corporate highlights
Feb 24,2020: Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones
Jan 15,2020: Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)
Nov 06,2019: Aeglea BioTherapeutics reports third quarter 2019 financial results and corporate highlights

This comprehensive SWOT profile of Aeglea BioTherapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aeglea BioTherapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,


- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Aeglea BioTherapeutics Inc - Key Information
Aeglea BioTherapeutics Inc - Overview
Aeglea BioTherapeutics Inc - Key Employees
Aeglea BioTherapeutics Inc - Key Employee Biographies
Aeglea BioTherapeutics Inc - Key Operational Heads
Aeglea BioTherapeutics Inc - Major Products and Services
Aeglea BioTherapeutics Inc - History
Aeglea BioTherapeutics Inc - Company Statement
Aeglea BioTherapeutics Inc - Locations And Subsidiaries
Aeglea BioTherapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Aeglea BioTherapeutics Inc - Business Description
Aeglea BioTherapeutics Inc - Corporate Strategy
Aeglea BioTherapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Aeglea BioTherapeutics Inc - Strengths
Aeglea BioTherapeutics Inc - Weaknesses
Aeglea BioTherapeutics Inc - Opportunities
Aeglea BioTherapeutics Inc - Threats
Aeglea BioTherapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Aeglea BioTherapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Aeglea BioTherapeutics Inc, Key Information
Aeglea BioTherapeutics Inc, Key Ratios
Aeglea BioTherapeutics Inc, Share Data
Aeglea BioTherapeutics Inc, Major Products and Services
Aeglea BioTherapeutics Inc, History
Aeglea BioTherapeutics Inc, Key Employees
Aeglea BioTherapeutics Inc, Key Employee Biographies
Aeglea BioTherapeutics Inc, Key Operational Heads
Aeglea BioTherapeutics Inc, Other Locations
Aeglea BioTherapeutics Inc, Subsidiaries
Aeglea BioTherapeutics Inc, Key Competitors
Aeglea BioTherapeutics Inc, SWOT Analysis
Aeglea BioTherapeutics Inc, Ratios based on current share price
Aeglea BioTherapeutics Inc, Annual Ratios
Aeglea BioTherapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Aeglea BioTherapeutics Inc, Performance Chart
Aeglea BioTherapeutics Inc, Ratio Charts
 


Aeglea BioTherapeutics Inc (AGLE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases.

USD 250 View Report

Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review

Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Gene Biotherapeutics Inc (CRXM) - Strategic SWOT Analysis Review

Gene Biotherapeutics Inc (CRXM) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available